iRhythm Technologies Inc. commenced a public offering of common shares for $100 million.
The San Francisco-based digital healthcare company also plans to offer underwriters a 30-day option to buy $15 million of additional shares.
J.P. Morgan and Morgan Stanley are joint lead book-running managers for the proposed offering.
